Likes Subject
The FDA has cleared an IND for LYL845. jondoeuk 10/09/22 8:23 PM
SITC titles jondoeuk 10/05/22 3:32 PM
recent technical advances using culture conditions with IL-7/IL-15 and NY1972 07/26/22 10:39 PM
The AEs from the LD chemo*. I expect jondoeuk 07/25/22 1:34 PM
Thanks for the link. NY1972 07/24/22 11:06 PM
For Epi-R, they use media with high concentrations jondoeuk 07/24/22 1:50 PM
Which will perform better ? BE with 7,8 NY1972 07/14/22 11:01 PM
That depends. Typically, the more the cells expand jondoeuk 07/13/22 3:01 PM
Do you need Epigenetic Reprogramming if pts can NY1972 07/11/22 11:27 AM
ISSCR poster https://ir.lyell.com/static-files/971404cb-28eb-46fc-839f-b20735899 jondoeuk 06/22/22 6:16 PM
Posters https://ir.lyell.com/static-files/d3a3d05c-1b39-4092-bf82-a486933bc268 jondoeuk 05/19/22 1:55 PM
1115: Epigenetic Reprogramming (Epi-R™) Yields T-Cell Receptor Products jondoeuk 05/02/22 4:59 PM
GSK has updated the master protocol for their jondoeuk 04/23/22 4:21 PM
AACR poster https://ir.lyell.com/static-files/ad2cd8dc-b41b-4536-a854-c4d1246422 jondoeuk 04/17/22 6:16 PM
The PhI (n=54) of LYL797 has now been jondoeuk 03/23/22 5:40 PM
A new review https://www.sciencedirect.com/science/article/pii/S0952791521001278 jondoeuk 11/08/21 2:44 PM
Morgan Stanley webcast https://morganstanley.webcasts.com/viewer/event.jsp?ei=14 jondoeuk 09/15/21 11:54 AM
New deck https://ir.lyell.com/static-files/96379999-4d8e-466b-a5d5-44f5f6f88583 jondoeuk 07/01/21 12:30 PM
Likes Subject

jondoeuk
10/09/22 8:23 PM
jondoeuk
10/05/22 3:32 PM
jondoeuk
07/25/22 1:34 PM
NY1972
07/24/22 11:06 PM
NY1972
07/14/22 11:01 PM
jondoeuk
03/23/22 5:40 PM

Lyell Immunopharma Inc (LYEL)

Followers
0
Posters
2
Posts (Today)
0
Posts (Total)
18
Created
06/18/21
Type
Free
Moderators
Most Liked Posts
(Last 30 Days)
New Post